Irene M. Ghobrial
Broad Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Multiple Myeloma Research and Treatments
Solid evidence · 1 supporting paper · latest 2026
Immune cells in cancer
Solid evidence · 1 supporting paper · latest 2026
CAR-T cell therapy research
Solid evidence · 2 supporting papers · latest 2026
Cancer Immunotherapy and Biomarkers
Solid evidence · 1 supporting paper · latest 2026
Immunotherapy and Immune Responses
Supporting evidence · 1 supporting paper · latest 2026
Publications (2)
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
2026DOI
Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma
2026DOIPMID 42693161
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Broad Institute
Source: ScienceWe Extractor · retrieved 2026-09-27